UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

(Check One):   [ ] Form 10-K  [ ] Form 20-F  [ ] Form 11-K  [X] Form 10-Q
                [ ] Form N-SAR

                      For Period Ended: September 30, 2004

         [   ] Transition Report on Form 10-K
         [   ] Transition Report on Form 20-F
         [   ] Transition Report on Form 11-K
         [   ] Transition Report on Form 10-Q
         [   ] Transition Report on Form N-SAR

         For Transition Period Ended:  Not Applicable.
________________________________________________________________________________
Nothing in this Form shall be construed to imply that the Commission has
verified any information contained herein.
________________________________________________________________________________

If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates: Not Applicable
________________________________________________________________________________

PART I--REGISTRANT INFORMATION
________________________________________________________________________________

Genemax Corp.
________________________________________________________________________________
Full Name of Registrant

________________________________________________________________________________
Former Name if Applicable

1681 Chestnut Street, Suite 400
________________________________________________________________________________
Address of Principal Executive Office (Street and Number)

Vancouver, British Columbia, Canada V6J 4M6
________________________________________________________________________________
City, State and Zip Code

PART II--RULES 12b-25 (b) AND (c)

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

            |    (a)      The reasons  described in  reasonable  detail in Part
            |             III of this  form  could  not be  eliminated  without
            |             unreasonable effort or expense;
            |
      [X]   |    (b)      The subject annual report, semi-annual report,
            |             transition report on Form 10-K, Form 20-F, 11-K or
            |             Form N-SAR, or portion thereof will be filed on or
            |             before the fifteenth calendar day following the
            |             prescribed due date; or the subject  quarterly report
            |             or transition report on Form 10-Q, or portion thereof
            |             will be filed on or  before  the fifth  calendar  day
            |             following the prescribed due date; and
            |
            |    (c)      The  accountant's statement or other exhibit required
            |             by Rule 12b-25(c) has been attached if applicable.

PART III--NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed period.

         The registrant is unable to file its annual report on Form 10-QSB for
the quarter ended September 30, 2004 within the prescribed period because of
delays in compiling financial information for disclosure in the 10-QSB.

PART IV--OTHER INFORMATION

(1)  Name and telephone number of person to contact in regard to this
     notification

              Henry F. Schlueter, Esq.         (303)              292-3883
         _______________________________________________________________________
                        (Name)               (Area Code)      (Telephone Number)

(2)      Have all other periodic  reports  required under Section 13 or 15(d) of
         the  Securities  Exchange  Act of 1934 or Section 30 of the  Investment
         Company Act of 1940 during the  preceding 12 months or for such shorter
         period that the  registrant  was required to file such  report(s)  been
         filed? If the answer is no, identify report(s). [X] Yes [ ] No
         _______________________________________________________________________

(3)      Is it anticipated that any significant  change in results of operations
         from  the  corresponding  period  for  the  last  fiscal  year  will be
         reflected  by the  earnings  statements  to be  included in the subject
         report or portion thereof? [ X ] Yes [ ] No

         If  so,  attach  an  explanation  of  the  anticipated   change,   both
         narratively and quantitatively,  and, if appropriate, state the reasons
         why a reasonable estimate of the results cannot be made.

         The Registrant expects that its net loss for the three months ended
         September 30, 2004 will be reduced by $581,800 or 44.4% as compared to
         the three months ended September 30, 2003 as a result of reduced
         consulting fees - stock based, reduced office and general expenses
         and reduced research and development activities.

                                  Genemax Corp.
                  ____________________________________________
                  (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.

Date:  November 17, 2004                   By: /s/ RONALD HANDFORD
________________________                   _____________________________________
                                                   Ronald Handford
                                                   Chief Executive Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly  authorized  representative.  The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.